ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 72 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,186,000 | +1.4% | 35,000 | -49.4% | 0.67% | -2.0% |
| Q4 2016 | $1,170,000 | +7.8% | 69,215 | +4.7% | 0.68% | -8.7% |
| Q3 2016 | $1,085,000 | +26.9% | 66,110 | +17.0% | 0.75% | +71.2% |
| Q2 2016 | $855,000 | +195.8% | 56,500 | +182.5% | 0.44% | +312.3% |
| Q1 2016 | $289,000 | -91.3% | 20,000 | -82.9% | 0.11% | -92.8% |
| Q4 2015 | $3,321,000 | +94.9% | 117,257 | +15.2% | 1.47% | +25.9% |
| Q3 2015 | $1,704,000 | – | 101,766 | – | 1.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,601,351 | $43,963,000 | 9.03% |
| Granite Point Capital Management, L.P. | 256,031 | $4,327,000 | 3.45% |
| Opaleye Management Inc. | 285,000 | $4,817,000 | 2.84% |
| Brenner West Capital Advisors | 1,221,463 | $20,643,000 | 2.28% |
| ARMISTICE CAPITAL, LLC | 536,000 | $9,058,000 | 2.14% |
| NEXTHERA CAPITAL LP | 151,670 | $2,563,000 | 1.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 185,234 | $3,130,000 | 1.41% |
| Cheyne Capital Management (UK) LLP | 144,765 | $2,448,000 | 1.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 270,000 | $4,563,000 | 1.16% |
| Mosaic Family Wealth, LLC | 123,314 | $2,084,000 | 0.96% |